Any guesses on $amount from the JV revenue anticipated will end up as profit?
I assume the JV will be a 50/50 split? My bad just saw 49/51
What are the odds of getting FDA approval in China and anticipated timeframe to get?
Based on current CMP figures of NPAT guidance of $5m on $40m rev = 12.5%
So on $66m AUD p.a could be $8m NPAT/2 (JV) ∼$4m NPAT over at CMP?
So just 1.5 x revenue and possibly doubled NPAT
Puts it at say $10m NPAT p.a, with 100m shares could well see $200m+ MCAP once implemented and factual.
Plenty of growth here it seems, hmmm on the watchlist, might even buy a few on the dips.
Any guesses on $amount from the JV revenue anticipated will end...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.025(8.47%) |
Mkt cap ! $61.50M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 29.0¢ | $132.1K | 428.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 21999 | 3 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |